Chang, Michelle A; Impoinvil, Daniel; Hamre, Karen ES; Dalexis, Paul-Emile; Mérilien, Jean-Baptiste; Dismer, Amber M; Fouché, Bernadette; Desir, Luccene; Holmes, Kathleen; Lafortune, Willy; +17 more... Herman, Camelia; Rogier, Eric; Noland, Gregory S; Young, Alyssa J; Druetz, Thomas; Ashton, Ruth; Eisele, Thomas P; Cohen, Justin; van den Hoogen, Lotus; Stresman, Gillian; Drakeley, Chris; Pothin, Emilie; Cameron, Ewan; Battle, Katherine E; Williamson, John; Telfort, Marc-Aurèle; Lemoine, Jean Frantz; (2023) Acceptability, Feasibility, Drug Safety, and Effectiveness of a Pilot Mass Drug Administration with a Single Round of Sulfadoxine-Pyrimethamine Plus Primaquine and Indoor Residual Spraying in Communities with Malaria Transmission in Haiti, 2018. The American journal of tropical medicine and hygiene, 108 (6). pp. 1127-1139. ISSN 0002-9637 DOI: https://doi.org/10.4269/ajtmh.22-0623
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Abstract
For a malaria elimination strategy, Haiti's National Malaria Control Program piloted a mass drug administration (MDA) with indoor residual spraying (IRS) in 12 high-transmission areas across five communes after implementing community case management and strengthened surveillance. The MDA distributed sulfadoxine-pyrimethamine and single low-dose primaquine to eligible residents during house visits. The IRS campaign applied pirimiphos-methyl insecticide on walls of eligible houses. Pre- and post-campaign cross-sectional surveys were conducted to assess acceptability, feasibility, drug safety, and effectiveness of the combined interventions. Stated acceptability for MDA before the campaign was 99.2%; MDA coverage estimated at 10 weeks post-campaign was 89.6%. Similarly, stated acceptability of IRS at baseline was 99.9%; however, household IRS coverage was 48.9% because of the high number of ineligible houses. Effectiveness measured by Plasmodium falciparum prevalence at baseline and 10 weeks post-campaign were similar: 1.31% versus 1.43%, respectively. Prevalence of serological markers were similar at 10 weeks post-campaign compared with baseline, and increased at 6 months. No severe adverse events associated with the MDA were identified in the pilot; there were severe adverse events in a separate, subsequent campaign. Both MDA and IRS are acceptable and feasible interventions in Haiti. Although a significant impact of a single round of MDA/IRS on malaria transmission was not found using a standard pre- and post-intervention comparison, it is possible there was blunting of the peak transmission. Seasonal malaria transmission patterns, suboptimal IRS coverage, and low baseline parasitemia may have limited the effectiveness or the ability to measure effectiveness.
Item Type | Article |
---|---|
Faculty and Department | Faculty of Infectious and Tropical Diseases > Department of Infection Biology |
Research Centre | Malaria Centre |
PubMed ID | 37160282 |
Elements ID | 205973 |
Official URL | http://dx.doi.org/10.4269/ajtmh.22-0623 |
Download
Filename: Chang-etal-2023-Acceptability-feasibility-drug-safety-and.pdf
Licence: Creative Commons: Attribution 4.0
Download